Health Enterprise Partners: Funding, Team & Investors

Loading organizations...

Health Enterprise Partners: Funding, Team & Investors | Startup Intros

About

Health Enterprise Partners is a healthcare private equity firm based in New York City, New York, that makes control and minority equity investments in lower middle market healthcare information technology and services companies. The firm targets companies with $10-50 million in revenue, leveraging capital and strategic insights to improve healthcare delivery. The firm has made over 36 investments, operates with fewer than 25 employees, and is funded by over 30 strategic payer and provider limited partners. Managing Partners include Dave Tamburri, Ezra Mehlman, and Pete Tedesco, alongside Founder and Partner Emeritus Bob Schulz. Portfolio companies include CenterPointe Behavioral Health System, JET Health, and Catapult Health, spanning behavioral health, home healthcare, and preventive health. Health Enterprise Partners was co-founded in 2004 by Bob Schulz and Rick Stowe.

Investment Activity

Health Enterprise Partners has 10 tracked investments across 7 companies. The latest tracked deal is $34.0M Series B in NOCD in January 2023.

Investments

7 companies

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 1, 2023	NOCD	$34.0M Series B	7wire Ventures, Craig Cimini	Advent Life Sciences, Draper Associates, F Prime Capital, General Catalyst, Global Ventures, Latitud, Maverick Capital, Picus Capital, Questa Capital, Curtis Chambers, Eight Roads Ventures, F Prime Capital, Kaiser Permanente Ventures, Longitude Capital
Mar 8, 2022	Wildflower Health	$26.0M Other Equity	Dawn Owens	Echo Health Ventures, Hatteras Venture Partners, Providence Ventures
Sep 1, 2021	NOCD	$33.0M Series B	JON LIM	7wire Ventures, Advent Life Sciences, Draper Associates, F Prime Capital, General Catalyst, Global Ventures, Latitud, Maverick Capital, Picus Capital, Questa Capital, Curtis Chambers, Chicago Ventures, Eight Roads Ventures, Daniel VAN DEN Bergh
Oct 1, 2020	NOCD	$12.0M Series A	Health Enterprise Partners	7wire Ventures, General Catalyst, Latitud, Picus Capital, Chicago Ventures, Hyde Park Angels
Apr 16, 2019	Bardy Diagnostics	$35.5M Series B	—	Aperture Venture Partners, Aphelion Capital, Ascension Ventures, Garheng Kong, Lumira Ventures, REX Health Ventures, SV Health Investors
Nov 2, 2016	Catapult Health	$10.0M Series B	—	David Michel, Deborah Michel, Jeff Smith, Ph.d., Uchealth
Nov 1, 2015	Evariant	$42.0M Series C	Jason Kreuziger, CFA	DST Global, Floodgate, Founders Fund, Greylock, GSV Acceleration, Kapor Capital, Lightspeed Venture Partners, NextView Ventures, Sequoia Capital, Seven Seven SIX, Sound Ventures, Streamlined Ventures, Theory Forge Ventures, True Ventures, ULU Ventures, Uncork Capital, Y Combinator, SAM Altman
Sep 16, 2014	Privia Health	$400.0M Other Equity	Thomas Carella	Brighton Health Partners, Cardinal Partners, Morgan Noble Healthcare Partners, Pamplona Capital Management
May 1, 2014	Evariant	$18.0M Series B	Lightspeed Venture Partners	DST Global, Floodgate, Founders Fund, Greylock, GSV Acceleration, Kapor Capital, NextView Ventures, Sequoia Capital, Seven Seven SIX, Sound Ventures, Streamlined Ventures, Theory Forge Ventures, True Ventures, ULU Ventures, Uncork Capital, Y Combinator, SAM Altman, Dignity Health, Salesforce Ventures
Jun 18, 2013	Vitals	$22.0M Series C	—	Cardinal Partners, Greycroft, Milestone Venture Partners, Thomas Schnettler